Dose-intensive chemotherapy including rituximab in Burkitt's leukemia or lymphoma regardless of human immunodeficiency virus infection status: final results of a phase 2 study (Burkimab)
Publication date:
2013-05-01
Publisher version:
Citación:
Cancer, 119(9), p. 1660-1668 (2013); doi:10.1002/cncr.27918
Descripción física:
p. 1660-1668
DOI:
Patrocinado por:
Supported in part by the grant RD12-0036-0029 from RTICC Instituto Carlos III, Spain.
Collections
Files in this item
Métricas
Compartir
